Report: Developing Opportunities within Itau Unibanco Banco Holding SA, NantHealth, Southern First Bancshares, uniQure N.V., Ascendis Pharma A/S, and National General — Future Expectations, Projections Moving into 2018

NEW YORK, March 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Itau Unibanco Banco Holding SA (NYSE:ITUB), NantHealth, Inc. (NASDAQ:NH), Southern First Bancshares, Inc. (NASDAQ:SFST), uniQure N.V. (NASDAQ:QURE), Ascendis Pharma A/S (NASDAQ:ASND), and National General Holdings Corp (NASDAQ:NGHC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

ITUB DOWNLOAD: http://Fundamental-Markets.com/register/?so=ITUB
NH DOWNLOAD: http://Fundamental-Markets.com/register/?so=NH
SFST DOWNLOAD: http://Fundamental-Markets.com/register/?so=SFST
QURE DOWNLOAD: http://Fundamental-Markets.com/register/?so=QURE
ASND DOWNLOAD: http://Fundamental-Markets.com/register/?so=ASND
NGHC DOWNLOAD: http://Fundamental-Markets.com/register/?so=NGHC

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Itau Unibanco Banco Holding SA (NYSE:ITUB), NantHealth, Inc. (NASDAQ:NH), Southern First Bancshares, Inc. (NASDAQ:SFST), uniQure N.V. (NASDAQ:QURE), Ascendis Pharma A/S (NASDAQ:ASND), and National General Holdings Corp (NASDAQ:NGHC) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 14th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

ITAU UNIBANCO BANCO HOLDING SA (ITUB) REPORT OVERVIEW

Itau Unibanco Banco Holding SA's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Itau Unibanco Banco Holding SA reported interest income of $11,267.55MM vs $12,605.93MM (down 10.62%) and basic earnings per share $0.29 vs $0.26 (up 12.21%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Itau Unibanco Banco Holding SA reported interest income of $46,300.62MM vs $45,119.98MM (up 2.62%) and basic earnings per share $1.02 vs $1.19 (down 14.19%). Itau Unibanco Banco Holding SA is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.29. The estimated EPS forecast for the next fiscal year is $1.30 and is expected to report on February 4th, 2019.

To read the full Itau Unibanco Banco Holding SA (ITUB) report, download it here: http://Fundamental-Markets.com/register/?so=ITUB

-----------------------------------------

NANTHEALTH, INC. (NH) REPORT OVERVIEW

NantHealth's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, NantHealth reported revenue of $21.76MM vs $20.66MM (up 5.31%) and basic earnings per share -$0.37 vs -$0.30. For the twelve months ended December 31st, 2016 vs December 31st, 2015, NantHealth reported revenue of $100.38MM vs $58.30MM (up 72.17%) and basic earnings per share -$1.57 vs -$0.72. NantHealth is expected to report earnings on May 9th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.24. The estimated EPS forecast for the next fiscal year is -$0.34 and is expected to report on March 13th, 2019.

To read the full NantHealth, Inc. (NH) report, download it here: http://Fundamental-Markets.com/register/?so=NH

-----------------------------------------

SOUTHERN FIRST BANCSHARES, INC. (SFST) REPORT OVERVIEW

Southern First Bancshares' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Southern First Bancshares reported interest income of $16.36MM vs $13.45MM (up 21.69%) and basic earnings per share $0.28 vs $0.52 (down 46.15%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Southern First Bancshares reported interest income of $61.21MM vs $51.19MM (up 19.57%) and basic earnings per share $1.86 vs $2.06 (down 9.71%). Southern First Bancshares is expected to report earnings on March 20th, 2018. The report will be for the fiscal period ending December 31st, 2017. The estimated EPS forecast for the next fiscal year is $2.65 and is expected to report on March 20th, 2018.

To read the full Southern First Bancshares, Inc. (SFST) report, download it here: http://Fundamental-Markets.com/register/?so=SFST

-----------------------------------------

UNIQURE N.V. (QURE) REPORT OVERVIEW

uniQure N.V's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, uniQure N.V reported revenue of $2.26MM vs $7.22MM (down 68.70%) and basic earnings per share -$0.40 vs -$0.61. For the twelve months ended December 31st, 2016 vs December 31st, 2015, uniQure N.V reported revenue of $25.10MM vs $10.58MM (up 137.27%) and basic earnings per share -$2.93 vs -$3.72. uniQure N.V is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.80. The estimated EPS forecast for the next fiscal year is -$3.37 and is expected to report on March 13th, 2019.

To read the full uniQure N.V. (QURE) report, download it here: http://Fundamental-Markets.com/register/?so=QURE

-----------------------------------------

ASCENDIS PHARMA A/S (ASND) REPORT OVERVIEW

Ascendis Pharma A/S's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Ascendis Pharma A/S reported revenue of $0.51MM vs $1.30MM (down 60.90%) and basic earnings per share -$1.22 vs -$0.80. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Ascendis Pharma A/S reported revenue of $5.10MM vs $9.01MM (down 43.46%) and basic earnings per share -$2.86 vs -$1.54. Ascendis Pharma A/S is expected to report earnings on March 28th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.55. The estimated EPS forecast for the next fiscal year is -$3.44 and is expected to report on March 28th, 2018.

To read the full Ascendis Pharma A/S (ASND) report, download it here: http://Fundamental-Markets.com/register/?so=ASND

-----------------------------------------

NATIONAL GENERAL HOLDINGS CORP (NGHC) REPORT OVERVIEW

National General's Recent Financial Performance

For the twelve months ended December 31st, 2017 vs December 31st, 2016, National General reported revenue of $4,430.87MM vs $3,553.39MM (up 24.69%) and basic earnings per share $0.70 vs $1.43 (down 51.05%). National General is expected to report earnings on May 14th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.38. The estimated EPS forecast for the next fiscal year is $2.55 and is expected to report on February 25th, 2019.

To read the full National General Holdings Corp (NGHC) report, download it here: http://Fundamental-Markets.com/register/?so=NGHC

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.